0001808665 false 0001808665 2023-07-27 2023-07-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares






Washington, D.C. 20549




(Amendment No. 1)



Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


July 27, 2023

Date of Report (Date of earliest event reported)





(Exact name of registrant as specified in its charter)




Delaware   001-39294   85-0598378
(State or Other Jurisdiction of
File Number)
  (IRS Employer
Identification Number)


100 South Saunders Rd., Suite 300
Lake Forest
, IL 60045

(Address of principal executive offices)(Zip Code)


(224) 419-7106

(Registrant’s telephone number, including area code)



(Former Name or Former Address, if Changed Since Last Report)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value  


  The Nasdaq Capital Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company         ¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ¨







Item 2.01 Completion of Acquisition or Disposition of Assets


On July 31, 2023, Assertio Holdings, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) disclosing the Company’s acquisition of Spectrum Pharmaceuticals, Inc., a Delaware corporation, pursuant to an Agreement and Plan of Merger, dated April 24, 2023 (the “Acquisition”). The Original Form 8-K stated that the Company intended to file the financial statements and pro forma financial information required by Item 9.01 of Form 8-K related to the Acquisition not later than 71 days after the required filing date of the Original Form 8-K.


Upon further analysis subsequent to the completion of the Acquisition, the Company determined that the financial statements and pro forma financial information are not required to be filed pursuant to Item 9.01 of Form 8-K. Accordingly, the Company hereby amends the Original Form 8-K to eliminate the references to the subsequent filing of financial statements and pro forma financial information relating to the Acquisition.


Item 9.01 Financial Statements and Exhibits


The disclosure contained in Items 9.01(a) and (b) of the Original Form 8-K is hereby deleted in its entirety.







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: October 10, 2023 ASSERTIO HOLDINGS, INC.
  By: /s/ Daniel A. Peisert
  Name: Daniel A. Peisert
  Title: President and Chief Executive Officer




Jul. 27, 2023
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag false
Document Period End Date Jul. 27, 2023
Entity File Number 001-39294
Entity Registrant Name ASSERTIO HOLDINGS, INC.
Entity Central Index Key 0001808665
Entity Tax Identification Number 85-0598378
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 100 South Saunders Rd
Entity Address, Address Line Two Suite 300
Entity Address, City or Town Lake Forest
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60045
City Area Code 224
Local Phone Number 419-7106
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value
Trading Symbol ASRT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Jan 2024 to Feb 2024 Click Here for more Assertio Charts.
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Feb 2023 to Feb 2024 Click Here for more Assertio Charts.